Outcomes of Risankizumab in Patients with Crohn's Disease and Prior Ustekinumab Exposure in a Multicenter Academic Institution.
Saved in:
| Title: | Outcomes of Risankizumab in Patients with Crohn's Disease and Prior Ustekinumab Exposure in a Multicenter Academic Institution. |
|---|---|
| Authors: | Vattikonda A; Department of Internal Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA. vattikonda.asrita@mayo.edu., Odah T; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA., Crosby S; Department of Pharmacy, Mayo Clinic, Jacksonville, FL, USA., Hashash JG; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA., Kinnucan JA; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA., Picco MF; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA., Farraye FA; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA. |
| Source: | Digestive diseases and sciences [Dig Dis Sci] 2026 Mar 25. Date of Electronic Publication: 2026 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7902782 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2568 (Electronic) Linking ISSN: 01632116 NLM ISO Abbreviation: Dig Dis Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1573-2568 |
|---|---|
| DOI: | 10.1007/s10620-026-09851-4 |
